Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

Clinical trial NCT03360747 · COMPLETED

Trial details

NCT number: NCT03360747
Sponsor: Akcea Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Familial Chylomicronemia Syndrome Lipoprotein Lipase Deficiency Hyperlipoproteinemia Type 1

Start date: 2017-12-21
Primary completion: 2018-06-12
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.